Heranba Industries Ltd

Heranba Inds Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Heranba Industries Ltd

₹ 453 -2.87%
21 Nov - close price
heranba.co.in BSE: 543266 NSE: HERANBA
About

Incorporated in 1994, Heranba Industries Ltd is engaged in the manufacturing of a diverse range of agrochemicals such as insecticides, herbicides, fungicides and public health products for pest control. [1]

Key Points

Product Portfolio
Heranba is an agrochemical company in India. It manufactures Synthetic Pyrethroids and its intermediates in India. It has a portfolio of 370+ products comprising intermediates, technicals and formulations for insecticides, herbicides, fungicides, and public health products.

Website BSE NSE
  • Market Cap ₹ 1,812 Cr.
  • Current Price ₹ 453
  • High / Low ₹ 562 / 278
  • Stock P/E 26.7
  • Book Value ₹ 223
  • Dividend Yield 0.28 %
  • ROCE 6.73 %
  • ROE 4.18 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Agro Chemicals Industry: Pesticides / Agrochemicals - Indian

Part of BSE Allcap BSE Commodities BSE SmallCap

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
362 421 276 260 275 424 300 258 296 437
316 355 252 240 279 380 275 246 256 378
Operating Profit 46 66 24 20 -4 44 24 12 40 60
OPM % 13% 16% 9% 8% -1% 10% 8% 5% 14% 14%
4 4 1 3 6 2 2 5 1 3
Interest 1 2 2 3 2 2 3 5 5 6
Depreciation 5 6 6 6 6 6 6 8 13 14
Profit before tax 44 63 16 15 -6 38 17 4 24 43
Tax % 24% 25% 23% 24% -9% 29% 18% 120% 30% 12%
33 47 13 11 -6 27 14 -1 17 38
EPS in Rs 8.35 11.78 3.16 2.79 -1.40 6.73 3.48 -0.08 4.19 9.49
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 TTM
1,319 1,257 1,291
1,163 1,180 1,155
Operating Profit 156 77 136
OPM % 12% 6% 11%
12 14 10
Interest 8 12 18
Depreciation 23 26 41
Profit before tax 138 52 87
Tax % 24% 34%
104 34 67
EPS in Rs 26.08 8.72 17.08
Dividend Payout % 5% 14%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 51%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -12%
1 Year: 27%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024 Sep 2024
Equity Capital 40 40 40
Reserves 770 803 853
93 165 237
259 469 622
Total Liabilities 1,162 1,477 1,751
209 445 425
CWIP 72 137 229
Investments 1 2 2
881 893 1,095
Total Assets 1,162 1,477 1,751

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
0 107
0 -241
0 62
Net Cash Flow 0 -72

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Mar 2024
Debtor Days 107 136
Inventory Days 126 116
Days Payable 78 122
Cash Conversion Cycle 154 129
Working Capital Days 131 103
ROCE % 7%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
74.77% 74.77% 74.83% 74.87% 74.87% 74.90% 74.94% 74.95% 74.95% 74.95% 74.95% 74.95%
2.62% 2.62% 2.27% 2.04% 1.37% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.40%
1.38% 1.57% 1.68% 1.45% 1.19% 1.21% 0.85% 0.29% 0.23% 0.23% 0.00% 0.00%
21.22% 21.03% 21.22% 21.63% 22.56% 23.89% 24.21% 24.76% 24.82% 24.83% 25.06% 24.67%
No. of Shareholders 92,12592,02994,39693,16693,33794,59693,08289,89588,22184,82281,43976,492

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls